About My Health Careers Internship MedBlogs Contact us

Once Weekly Insulin can Help Improve Treatment Outcomes in Diabetic Patients

by Pooja Shete on November 28, 2020 at 8:54 PM
Font : A-A+

Once Weekly Insulin can Help Improve Treatment Outcomes in Diabetic Patients

The authors of the study have suggested that once-weekly insulin therapy would be easier for patients with type-2 diabetes than taking daily insulin injections especially in patients who are still learning about how to use insulin injections.

The study was published in New England Journal of Medicine


There is an increasing incidence of type-2 diabetes and related complications due to poor blood sugar control. The treatment for diabetes still is less than ideal even with introduction of recombinant insulin, adjunctive therapy, and real time glucose monitoring.

Currently, for treatment of diabetes the first line therapy is oral anti-diabetics and lifestyle changes. In order to maintain a good control of blood sugar, additional therapies are added. Anti-diabetic agents like glucagon-like peptide 1 (GLP-1) receptor agonists and sodium glucose-like transporter 2 (SGLT2) inhibitors have minimal risk of hypoglycemia and weight gain.

In patients whom the oral agents are ineffective, newer therapies and basal insulin dosing are required. Hence researchers Rosenstock and colleagues have tried to simplify basal insulin therapy in patients with type-2 diabetes with ultra-long acting basal insulin called icodec which can be administered once in a week.

Clinical Trial

The researchers compared weekly insulin icodec with daily insulin glargine U100 in clinical trial. The results of this study were that icodec was associated with no major adverse effects and was as effective as glargine in lowering blood sugar levels.

The incidence of hypoglycemia was slightly higher with icodec but less aggressive dose adjustment can help reduce the risk of hypoglycemia. Hypoglycemia is decrease in blood sugar and the symptoms include confusion, anxiety, palpitations, shakiness.

There is an increasing number of treatment options for patients with type-2 diabetes hence the particular participants which were included in the trial might not represent the typical patient with diabetes. Therefore further studies are needed to determine how once-weekly insulin can be incorporated in the standard of treatment algorithms.

The inability to vary the dose poses a problem for patients who are trying to incorporate exercise into their care regimen.

Patients with type 1 diabetes (destruction of insulin producing cell) can benefit from less frequent administration of insulin. However these patients need the ability to adjust the doses of long and short acting insulin.

Despite the concerns, this trial represents a new drug which can be added for lowering blood sugar. Further studies are required to understand the group of patients which will benefit the most from this study.

Source: Medindia

News A-Z
News Category
What's New on Medindia
Black Tea Protects against Blood Pressure and Heart Diseases
Green Mediterranean Diet may Help Repair Age-Related Brain Damages
Cervical Cancer Awareness Month 2022
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Diabetes and Exercise Gestational diabetes Pregnancy and Complications Glycemic Index Type 2 Diabetes Decoding HbA1c Test for Blood Sugar Diabetes - Foot Care Diabesity 

Recommended Reading
HIV Medications Could Prevent Diabetes: Study
Group of drugs used to treat HIV and hepatitis B could be repurposed to prevent type 2 diabetes, a ....
Scientists Identify New Way of Insulin Secretion, Aiding Treatment
New unknown way that pancreatic cells decide how much insulin to secrete could provide a promising ....
Molecular Link Between Liver Disease, Insulin Resistance Discovered
Two separate lipids namely diacylglycerols and ceramides are identified as potential links between ....
Air Pollution can Impair Glucose and Insulin Tolerance
Living in a densely polluted environment is as bad as eating a high-fat diet. Apart from causing ......
Decoding HbA1c Test for Blood Sugar
The HbA1c assay is the gold-standard measurement of chronic glycemia and measures the amount of gluc...
With more than one billion people affected, diabesity is the largest epidemic in the world today. Fo...
Diabetes - Essentials
Diabetes is a metabolic disease caused by insulin deficiency that leads to high blood sugar levels a...
Diabetes - Foot Care
Valuable information on diabetic foot care, treatment and prevention....
Diabetes - Self-Monitoring of Blood Glucose (SMBG)
Self-Monitoring Of Blood Glucose (SMBG) is one of the greatest advancements in the management of Di...
Diabetes and Exercise
Regular exercise especially in type II diabetes not only helps reduce the sugar but also reduces the...
Gestational diabetes
The condition is not caused by a lack of insulin, but by the action of hormones produced during preg...
Glycemic Index
GLYCEMIC INDEX (GI) is a scale which helps to rank carbohydrate- rich foods, depending on how they a...
Pregnancy and Complications
In-depth guide for expecting mothers to overcome health complications related to early or late pregn...
Type 2 Diabetes
Globalization and changing lifestyles has made diabetes very common in developing countries so much ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)